Goldberg Mark Alan

Director at ImmunoGen, Inc.; Director at BPMC; EVP, Medical & Reg. Strategy at TRIMERIS INC

Sold, on record
$8.5M
Dollars the filings state
Form 4 sales
16
Latest Dec 24, 2020
Form 144 notices
1
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TRIMERIS INCUnusual
    Sep 19, 2014 2014

    Sold 790 shares at $65.24 ($52k)

    Goldberg Mark Alan, EVP, Medical & Reg. Strategy

    Sold 58.4% of holdings ($88k position)562 shares left0.1x usual sizeFiling

  2. 2 Form 4 sale BPMCUnusual
    Oct 7, 2020 +2210 days

    Sold 5,454 shares at $100.00 ($545k)

    Goldberg Mark Alan, Director

    Sold 60.5% of holdings ($902k position)3,562 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale BPMCUnusual
    Oct 19, 2020 +12 days

    Sold 5,455 shares at $105.00 ($573k)

    Goldberg Mark Alan, Director

    Sold 60.5% of holdings ($947k position)3,562 shares leftFiling

  4. 4 Form 4 sale BPMCUnusual
    Dec 1, 2020 +43 days

    Sold 5,454 shares at $110.00 ($600k)

    Goldberg Mark Alan, Director

    Sold 60.5% of holdings ($992k position)3,562 shares leftFiling

  5. 5 Form 4 sale BPMCUnusual
    Dec 11, 2020 +10 days

    Sold 5,455 shares at $115.00 ($627k)

    Goldberg Mark Alan, Director

    Sold 60.5% of holdings ($1M position)3,562 shares left1x usual sizeFiling

  6. 6 Form 4 sale BPMCUnusual
    Dec 18, 2020 +7 days

    Sold 5,454 shares at $120.00 ($654k)

    Goldberg Mark Alan, Director

    Sold 60.5% of holdings ($1.1M position)3,562 shares left1x usual sizeFiling

  7. 7 Form 4 sale BPMCUnusual
    Dec 24, 2020 +6 days

    Sold 5,455 shares at $125.00 ($682k)

    Goldberg Mark Alan, Director

    Sold 60.5% of holdings ($1.1M position)3,562 shares left1x usual sizeFiling

  8. 8 Form 144 notice ImmunoGen, Inc.Notice
    Oct 30, 2023 +1040 days

    Filed to sell 10,000 shares ($151k)

    Goldberg Mark Alan, Director

    10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Goldberg Mark Alan
Source
Oct 30, 2023Oct 30, 2023ImmunoGen, Inc.DirectorForm 144 notice10,000$151kNoticeSEC
Dec 24, 2020Dec 28, 2020BPMCDirectorForm 4 sale5,455$682k60.5%UnusualSEC
Dec 18, 2020Dec 22, 2020BPMCDirectorForm 4 sale5,454$654k60.5%UnusualSEC
Dec 11, 2020Dec 15, 2020BPMCDirectorForm 4 sale5,455$627k60.5%UnusualSEC
Dec 1, 2020Dec 3, 2020BPMCDirectorForm 4 sale5,454$600k60.5%UnusualSEC
Oct 19, 2020Oct 21, 2020BPMCDirectorForm 4 sale5,455$573k60.5%UnusualSEC
Oct 7, 2020Oct 9, 2020BPMCDirectorForm 4 sale5,454$545k60.5%UnusualSEC
Sep 19, 2014Sep 19, 2014TRIMERIS INCEVP, Medical & Reg. StrategyForm 4 sale790$52k58.4%UnusualSEC
Sep 17, 2014Sep 18, 2014TRIMERIS INCEVP, Medical & Reg. StrategyForm 4 sale13,579$883k96.0%UnusualSEC
Jun 11, 2014Jun 12, 2014TRIMERIS INCEVP, Medical & Reg. StrategyForm 4 sale21,597$1.7M97.9%UnusualSEC
Dec 3, 2013Dec 4, 2013TRIMERIS INCSVP,Medical&Regulatory AffairsForm 4 sale7,000$424k96.3%UnusualSEC
Nov 1, 2013Nov 4, 2013TRIMERIS INCSVP,Medical&Regulatory AffairsForm 4 sale7,000$350k96.3%UnusualSEC
Oct 1, 2013Oct 3, 2013TRIMERIS INCSVP,Medical&Regulatory AffairsForm 4 sale7,000$450k96.3%UnusualSEC
Apr 1, 2013Apr 3, 2013TRIMERIS INCSVP,Medical&Regulatory AffairsForm 4 sale4,416$240k100.0%UnusualSEC
Mar 1, 2013Mar 6, 2013TRIMERIS INCSVP, Product DevelopmentForm 4 sale4,417$224k100.0%UnusualSEC
Feb 1, 2013Feb 5, 2013TRIMERIS INCSVP, Product DevelopmentForm 4 sale4,417$211k100.0%UnusualSEC
Jan 2, 2013Jan 4, 2013TRIMERIS INCSVP, Product DevelopmentForm 4 sale4,417$210k100.0%UnusualSEC